Search Results - "Pampanelli, S."
-
1
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
Published in Diabetes (New York, N.Y.) (01-12-2000)“…Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and…”
Get full text
Journal Article -
2
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin
Published in Diabetic medicine (01-11-2004)“…Background Glargine is a long‐acting insulin analogue potentially more suitable than NPH insulin in intensive treatment of Type 1 diabetes mellitus (T1 DM),…”
Get full text
Journal Article -
3
Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes
Published in Diabetic medicine (01-03-2006)“…Aims To compare long‐term (1 year) efficacy and safety of pioglitazone and gliclazide in patients with Type 2 diabetes. Methods This was a double‐blind,…”
Get full text
Journal Article -
4
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime
Published in Diabetes care (01-03-1999)“…Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. C Lalli , M…”
Get full text
Journal Article -
5
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia
Published in Diabetologia (01-02-2007)“…Aims/hypothesis The aim of our study was to establish whether the well-known defective or absent secretion of glucagon in type 1 diabetes in response to…”
Get full text
Journal Article -
6
Brief elevation of hepatic enzymes due to liver ischemia in anorexia nervosa
Published in Eating and weight disorders (01-12-2010)“…Abnormal liver function is occasionally observed in patients affected by anorexia nervosa. Although numerous studies report a strong relation between…”
Get full text
Journal Article -
7
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
Published in Diabetes (New York, N.Y.) (01-11-1993)“…Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive…”
Get full text
Journal Article -
8
Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial
Published in Diabetic medicine (01-05-2005)“…Aims This randomized, multi‐centre, double‐blind, stratified, two period, cross‐over trial was undertaken to assess the pharmacokinetics and pharmacodynamics…”
Get full text
Journal Article -
9
Factors affecting dropout in outpatient eating disorder treatment
Published in Eating and weight disorders (01-12-2006)“…To evaluate the incidence and effects of factors potentially influencing eating disordered patients' dropping out of outpatient cognitive-behavioural therapy…”
Get full text
Journal Article -
10
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM
Published in Diabetologia (01-12-1994)“…Hypoglycaemia unawareness, is a major risk factor for severe hypoglycaemia and a contraindication to the therapeutic goal of near-normoglycaemia in IDDM. We…”
Get full text
Journal Article -
11
Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal
Published in Diabetic medicine (01-07-1998)“…To establish whether lispro may be a suitable short‐acting insulin preparation for meals in intensive treatment of Type 1 diabetes mellitus (DM) in patients…”
Get full text
Journal Article -
12
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect
Published in Diabetes (New York, N.Y.) (01-05-1997)“…Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. P Bottini , E…”
Get full text
Journal Article -
13
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM
Published in Diabetes (New York, N.Y.) (01-06-1997)“…Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. G Perriello , S Pampanelli , P Del Sindaco , C Lalli , M…”
Get full text
Journal Article -
14
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans
Published in The Journal of clinical investigation (01-10-1993)“…In vitro studies indicate that FFA compete with glucose as an oxidative fuel in muscle and, in addition, stimulate gluconeogenesis in liver. During…”
Get full text
Journal Article -
15
Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans
Published in Diabetologia (01-08-1994)“…To assess the relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses, symptoms and deterioration of cognitive function (12…”
Get full text
Journal Article -
16
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM
Published in Diabetes care (01-09-1996)“…Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. E Torlone , S Pampanelli , C Lalli , P Del…”
Get full text
Journal Article -
17
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM
Published in Diabetologia (01-07-1994)“…The aim of these studies was to compare the pharmacokinetics, pharmacodynamics, counterregulatory hormone and symptom responses, as well as cognitive function…”
Get full text
Journal Article -
18
Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation
Published in Diabetes (New York, N.Y.) (01-07-1997)“…Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. C Fanelli , S…”
Get full text
Journal Article -
19
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function
Published in Diabetes care (01-11-1995)“…Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic…”
Get full text
Journal Article -
20
Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state
Published in Diabetologia (2003)“…The aim of this study was to establish the effect of a rate of decreasing plasma glucose concentrations on responses to hypoglycaemia, i.e. release of…”
Get full text
Journal Article